Mckee William
SEC-identified person · CIK 1237262 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Assertio Holdings, Inc. ASRT | Director | filed 2020–2026 |
| Rein Therapeutics, Inc. RNTX | Director | filed 2019–2022 |
| C4 Therapeutics, Inc. CCCC | Chief Financial Officer | filed 2020–2020 |
| Agile Therapeutics INC AGRX | Director | filed 2014–2019 |
| Depomed INC DEPO | Director | filed 2017–2019 |
| Dare Bioscience, Inc. DARE | Director | filed 2014–2017 |
| Auxilium Pharmaceuticals INC AUXL | Director | filed 2009–2015 |
| Barr Pharmaceuticals INC BRL | Sr.VP, CFO & Treasurer | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.